DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

TORONTO, July 25, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that the Trust intends to participate in the following investor conferences in 2023:

Canaccord Genuity Annual Growth Conference

Date: August 9, 2023
Presentation time: 9:30 am ET
City: Boston, Massachusetts
Event URL: https://www.canaccordgenuity.com/capital-markets/about-us/events/43rd-annual-growth-conference/

CIBC 22nd Annual Eastern Institutional Conference

Date: September 28, 2023
Presentation time: TBD
City: Montreal, Quebec

Truist 2023 BioPharma Symposium

Date: November 8, 2023
Presentation time: TBD
City: New York, New York

UBS Biopharma Conference

Date: November 8-9, 2023
Presentation time: TBD
City: Miami, Florida

About DRI Healthcare Trust

DRI Healthcare Trust is managed by DRI Capital Inc. (“DRI Capital”), the pioneer in global pharmaceutical royalty monetization with a more than 30-year history of accelerating innovation by providing capital to inventors, academic institutions and biopharma companies. Since its founding in 1989, DRI Capital has deployed more than US$2.5 billion, acquiring more than 70 royalties on 40-plus drugs, including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara. DRI Healthcare Trust’s units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol “DHT.UN” and in U.S. dollars under the symbol “DHT.U”. To learn more, visit drihealthcare.com or follow us on LinkedIn.

SOURCE DRI Healthcare Trust


Recent Posts

Presentation at 2024 RBC Capital Markets Global Healthcare Conference

2024 Annual Meeting of Unitholders

DRI Healthcare Trust Announces Voting Results of AGM